je.st
news
Tag: gilead
Gilead Sciences, Atlas Energy And Others Insiders Have Been Buying
2015-02-15 05:41:45| Energy - Topix.net
Weak earnings and outlooks have recently prompted some insiders to purchase shares, even as markets take aim for new record highs. Gilead Sciences, Atlas Energy and Intrexon were among those that have seen significant insider buys.
Tags: energy
buying
sciences
atlas
Gilead: No Reason To Panic Here
2015-02-13 18:15:55| Biotech - Topix.net
The shares of biotech juggernaut Gilead Sciences have been under pressure recently due to concerns of expanded discounted pricing within its hepatitis C franchise. Lower prices will also beget a much larger prescription base offsetting the impacts of discounts significantly.
French charity attacks Gilead patent for hepatitis drug
2015-02-10 12:23:32| Biotech - Topix.net
French charity Medecins du Monde on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly. The organisation-"Doctors of the World"-said it had filed a "brief in opposition" with the European Patent Office , the Munich-based agency that awards patents covering 40 European countries.
Tags: french
drug
patent
attacks
Gilead Sciences to Present at Two Upcoming Investor Conferences
2015-02-10 10:19:04| Biotech - Topix.net
Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from two upcoming investor conferences: the 17 th Annual BIO CEO & Investor Conference and the 2015 Leerink Global Healthcare Conference, both taking place in New York. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the BIO CEO conference on Tuesday, February 10 at 10:00 a.m. Eastern Time and the Leerink conference on Wednesday, February 11 at 10:15 a.m. ET.
Tags: present
sciences
upcoming
investor
Gilead Sciences, Mobiquity make significant healthcare investment in London
2015-02-09 16:30:46| Biotech - Topix.net
London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment by two leading US companies, announced today as Mayor of London Boris Johnson visited Boston as part of a trade delegation to the East Coast of the USA. Gilead Sciences, a Fortune 500 US biotechnology company, is deepening its UK presence with a new commercial HQ in the heart of London from which to grow the company's portfolio, which includes treatments for HIV/Aids, liver diseases, serious respiratory and cardiovascular diseases and cancer.
Tags: make
significant
london
investment
Sites : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »